Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

10 terminated/withdrawn out of 40 trials

Success Rate

73.0%

-13.6% vs industry average

Late-Stage Pipeline

13%

5 trials in Phase 3/4

Results Transparency

111%

30 of 27 completed trials have results

Key Signals

1 recruiting30 with results10 terminated

Enrollment Performance

Analytics

N/A
13(56.5%)
Phase 4
5(21.7%)
Phase 2
5(21.7%)
23Total
N/A(13)
Phase 4(5)
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials
NCT07118358Not ApplicableRecruiting

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Role: lead

NCT06540079Not ApplicableCompleted

BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Role: lead

NCT04175626Completed

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Role: lead

NCT04190186Not ApplicableCompleted

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Role: collaborator

NCT05251363Not ApplicableCompleted

BIOTRONIK Conduction System Pacing With the Solia Lead

Role: lead

NCT03884608Completed

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Role: lead

NCT04683718Not ApplicableActive Not Recruiting

A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management

Role: lead

NCT03594266Not ApplicableCompleted

Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)

Role: lead

NCT03361189Phase 2Terminated

Specialized Pacing for Patients With Congenital Heart Disease

Role: collaborator

NCT02389946Not ApplicableCompleted

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Role: lead

NCT04076917Terminated

Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection

Role: lead

NCT04870281Terminated

Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System

Role: lead

NCT02693262Not ApplicableCompleted

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds

Role: collaborator

NCT02290028Not ApplicableTerminated

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Role: collaborator

NCT03155724Not ApplicableCompleted

QP ExCELs: MultiPole Pacing (MPP) Sub-Study

Role: lead

NCT03103503Terminated

Plexa ICD Lead Registry

Role: lead

NCT02243696Terminated

Protego DF4 Post Approval Registry

Role: lead

NCT01791127Terminated

Safety and Performance Study of the Siello S Pacing Lead

Role: lead

NCT00810264Completed

Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

Role: lead

NCT02682251Not ApplicableCompleted

Engaging Patients in Heart Failure Management

Role: collaborator